Technical Analysis for CRBP - Corbus Pharmaceuticals Holdings, Inc.
Trend Table & Recent Alerts
|Weak or Absent||Down||Down||Up|
|See historical CRBP trend table...|
|Date||Alert Name||Type||% Chg|
|Jun 26||50 DMA Resistance||Bearish||0.00%|
|Jun 26||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||0.00%|
|Jun 23||Volume Surge||Other||-0.79%|
|Jun 23||MACD Bullish Signal Line Cross||Bullish||-0.79%|
|Jun 21||Bearish Engulfing||Bearish||5.88%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Corbus Pharmaceuticals Holdings, Inc., a clinical stage biopharmaceutical company, develops and commercializes novel therapeutics to treat inflammatory-fibrotic diseases. The company primarily develops Resunab, an oral anti-inflammatory drug that has completed Phase I clinical trials for the treatment of cystic fibrosis and diffuse scleroderma. It sells its products through hearing professionals, including audiologists, hearing aid specialists, and ENT doctors worldwide. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
Is CRBP a Buy, Sell or Hold?
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more CRBP news...
|52 Week High||10.78|
|52 Week Low||2.68|
|200-Day Moving Average||7.4042|
|50-Day Moving Average||6.414|
|20-Day Moving Average||6.21|
|10-Day Moving Average||6.01|
|Average True Range||0.3995|
|Chandelier Exit (Long, 3 ATRs)||5.8515|
|Chandelier Exit (Short, 3 ATRs)||6.7985|
|Upper Bollinger Band||6.8923|
|Lower Bollinger Band||5.5277|
|Percent B (%b)||0.57|
|MACD Signal Line||-0.1673|